ArticleInternational journal of molecular sciences2023
A New Method to Detect Variants of SARS-CoV-2 Using Reverse Transcription Loop-Mediated Isothermal Amplification Combined with a Bioluminescent Assay in Real Time (RT-LAMP-BART).
Takahiro Iijima, Jun Sakai, Dai Kanamori, Shinnosuke Ando, Tsutomu Nomura, Laurence Tisi, Paul E Kilgore, Neil Percy, Hikaru Kohase, Satoshi Hayakawa and 3 more
Open access · goldAbstract read
In one paragraphArticle in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 4 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors at 5 institutions in 2 countries.
Takahiro IijimaDivision of Pediatric Dentistry, Department of Human Development and Fostering, Meikai University School of Dentistry, Sakado 350-0283, Japan.
Jun SakaiDepartment of Infectious Disease and Infection Control, Saitama Medical University, Moroyama 350-8550, Japan.
Dai KanamoriDivision of Pediatric Dentistry, Department of Human Development and Fostering, Meikai University School of Dentistry, Sakado 350-0283, Japan.
Shinnosuke AndoDivision of Dental Anesthesiology, Department of Diagnostic and Therapeutic Sciences, Meikai University School of Dentistry, Sakado 350-0248, Japan.
Tsutomu NomuraDivision of Otolaryngology, Department of Comprehensive Medical Sciences, Meikai University School of Dentistry, Sakado 350-0248, Japan.
Laurence TisiErba Molecular-Lumora, Ely CB7 4EA, UK.
Paul E KilgoreDepartment of Pharmacy Practice, Eugene Applebaum College of Pharmacy & Health Sciences, Wayne State University, Detroit, MI 48201, USA.ORCID 0000-0003-3214-4482 Neil Percy3M Company, St. Paul, MN 55144, USA.
Hikaru KohaseDivision of Dental Anesthesiology, Department of Diagnostic and Therapeutic Sciences, Meikai University School of Dentistry, Sakado 350-0248, Japan.ORCID 0000-0002-9157-7029 Satoshi HayakawaDivision of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo 113-8602, Japan.ORCID 0000-0002-1022-1443 Shigefumi MaesakiDepartment of Infectious Disease and Infection Control, Saitama Medical University, Moroyama 350-8550, Japan.
Tomonori HoshinoDivision of Pediatric Dentistry, Department of Human Development and Fostering, Meikai University School of Dentistry, Sakado 350-0283, Japan.
Mitsuko SekiDivision of Pediatric Dentistry, Department of Human Development and Fostering, Meikai University School of Dentistry, Sakado 350-0283, Japan.
Meikai University · JPNihon University · JPSaitama Medical University · JP3M (United States) · USEugene Applebaum College of Pharmacy and Health Sciences · US
Funding
Japan Society for the Promotion of Science JP22K16376Meikai University Miyata Research Grant (A)Meikai University Miyata Research Grant (E)Nihon University Nihon University Research Grant for 2022
6 · The paper itselfAbstract
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), of which there are several variants. The three major variants (Alpha, Delta, and Omicron) carry the N501Y, L452R, and Q493R/Q498R mutations, respectively, in the
Indexed as
COVID-19SARS-CoV-2HumansLuminescent MeasurementsMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesReverse TranscriptionRNARNA, ViralSensitivity and SpecificitySpike Glycoprotein, CoronavirusRNARNA, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2loop-mediated isothermal amplificationSARS-CoV-2spike proteinvariants of concern
Identifiers
PMID37445876
PMCPMC10341676
OpenAlexW4382582184
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390